Abbott Laboratories

ABT Names New Executives

Abbott Laboratories
14 March 2003

Health Care Worldwide

Abbott Laboratories
Corporate Communications
Abbott Park, Illinois 60064-6096

                                                      For Immediate Release

                                                      Melissa Brotz
                                                      (847) 935-3456

                                                          - or -

                                                      Kathleen Gilgunn
                                                      (847) 938-3895

                                                      Financial Community
                                                      John Thomas
                                                      (847) 938-2655


ABBOTT PARK, Ill., March 14, 2003 - Abbott Laboratories today announced that
William G. Dempsey has been named senior vice president, pharmaceutical
operations, for Abbott's U.S. pharmaceutical business.  Guillermo A. Herrera has
been named senior vice president, international operations, and replaces Dempsey
who held the position since 1999.  The appointments are effective immediately.

Both Dempsey and Herrera will report to Jeffrey M. Leiden, M.D., Ph.D.,
president and chief operating officer, Pharmaceutical Products Group, Abbott

Dempsey, 51, joined Abbott in 1982.  He most recently served as senior vice
president, international operations, and led the highly successful integration
of BASF's pharmaceutical business, which included the global operations of
Knoll.  Dempsey has spent over 20 years at Abbott and has held a number of
management positions.  He holds a bachelor's degree in accounting from DePaul

Since June 2001, Herrera, 49, has served as vice president, European operations
for Abbott's international division.  He has more than 20 years of Abbott
service and has held various managerial positions in the company's international
division including vice president, Latin America and Canada.  Herrera earned a
bachelor's degree in industrial economics from Universidad del Valle in
Colombia, South America, and a master's degree in business administration from
Northwestern University's Kellogg Graduate School of Management.

'Bill Dempsey and Guillermo Herrera are experienced Abbott leaders with a
long-standing history of excellent performance and results,' Miles D. White,
Abbott's chairman and chief executive officer, said.  'We're fortunate to have
Bill and Guillermo to lead these businesses as we begin to launch significant
products emerging from our pipeline.'

Abbott Laboratories is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals,
nutritionals, and medical products, including devices and diagnostics.  The
company employs more than 70,000 people and markets its products in more than
130 countries.  In 2002, the company's sales and net earnings were $17.7 billion
and $3.2 billion, respectively, with diluted earnings per share of $2.06,
excluding one-time charges.

Abbott's news releases and other information are available on the company's Web
site at


                      This information is provided by RNS
            The company news service from the London Stock Exchange